KBC Group
SWAV

KBC Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

KBC Group’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-792
Closed -$258K – 1927
2024
Q1 		$258K Buy
792
+81
+11% +$19.9K ﹤0.01% 798
2023
Q4 		$135K Hold
711
– – ﹤0.01% 944
2023
Q3 		$142K Buy
+711
New +$168K ﹤0.01% 885

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

KBC Group's SWAV Position: Q2 2024 in Review

KBC Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 792 shares — an estimated $258K sold.

KBC Group first reported a position in SWAV in Q3 2023 and held it in 3 quarters. The position peaked at $258K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • KBC Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • KBC Group sold 792 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $258K.
  • KBC Group first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
  • KBC Group's Shockwave Medical, Inc. Common Stock position peaked at $258K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on KBC Group's 13F filing for Q2 2024, filed 17 Jul 2024.